Amplyx Pharmaceuticals' Series A - III Round

Amplyx Pharmaceuticals raised a round of funding on February 23, 2011. Investors include Ariel Savannah Angel Partners.

Amplyx Pharmaceuticals is a pre-clinical stage small molecule drug development company with a portfolio of internally discovered candidates with improved the therapeutic properties. Amplyx's platform …

Articles about Amplyx Pharmaceuticals' Series A - III Round: